Ignite Creation Date:
2025-12-25 @ 3:32 AM
Ignite Modification Date:
2026-02-22 @ 7:25 AM
Study NCT ID:
NCT01437605
Status:
TERMINATED
Last Update Posted:
2019-12-20
First Post:
2011-09-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Study to Assess the Safety and Immunogenicity of recMAGE-A3+AS15 ASCI With or Without Poly IC:LC
Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-10-11
Start Date Type:
ACTUAL
Primary Completion Date:
2018-07-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-07-18
Completion Date Type:
ACTUAL
First Submit Date:
2011-09-19
First Submit QC Date:
None
Study First Post Date:
2011-09-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-07-18
Results First Submit QC Date:
None
Results First Post Date:
2019-12-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-12-18
Last Update Post Date:
2019-12-20
Last Update Post Date Type:
ACTUAL